egtazic acid has been researched along with cd 437 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carminati, P; Chiarucci, I; Diomede, L; Ferrara, FF; Garattini, E; Gianni', M; Kalac, Y; Merlini, L; Parrella, E; Pisano, C; Simoni, D; Terao, M; Zanier, R | 1 |
1 other study(ies) available for egtazic acid and cd 437
Article | Year |
---|---|
ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis.
Topics: Adamantane; Antineoplastic Agents; Apoptosis; Calcium; Cell Line, Tumor; Chelating Agents; Cinnamates; Dihydropyridines; Egtazic Acid; Gene Expression; HeLa Cells; Homeostasis; Humans; Intracellular Fluid; JNK Mitogen-Activated Protein Kinases; Leukemia, Myeloid; Mitochondria; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids | 2004 |